With cruise ship voyages reporting additional norovirus outbreaks in 2025, vaccines that protect people against human norovirus disease are in demand.
Historically, developing a broadly effective norovirus vaccine has been challenging owing to the genetic and antigenic diversity of noroviruses.
Another concern has arisen due to Moderna Inc.'s recent announcement.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
